Drawing for HINGE THERAPEUTICS

USPTO serial 87405017

HINGE THERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JOHNSON, AISHA CLARKE
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HINGE THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian R. Coleman

Brian R. Coleman PERKINS COIE LLP3150 PORTER DRIVEPALO ALTO, CA 94304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009computer software used for collection, organization, analysis, integration and communication of scientific data; computer hardware; mobile computing and operating platforms consisting of data transceivers, wireless networks and gateways for collection and management of data; computer software platforms for diagnostic drug discoveryACTIVE—
035providing an online computer database for collecting and reporting diagnostic drug discovery and protein structures; business research and surveys; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approvalACTIVE—
042pharmaceutical product and technology consultation and screening services; software as a service (SAAS) in the fields of business research and surveys; SAAS in the fields of business consulting and management of clinical trials; SAAS in the fields of clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies; SAAS, technical support and research services to assist medical, biopharmaceutical and biotechnology companies with scientific research, clinical research, clinical trials and applications for drug approval; technical support services, namely, installation, administration, and troubleshooting of computer software and software platforms for use in online database management in the field of drug discovery and researchACTIVE—
044medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing information related to diagnostic drug discoveryACTIVE—
045providing an on-line interactive database featuring legal information; providing legal research services for on-line databasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 15, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 15, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 10, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 10, 2020NOACCORRECTED NOA E-MAILED—
Jun 9, 2020DPCCDIVISIONAL PROCESSING COMPLETE—
Jun 9, 2020EX5GSOU EXTENSION 5 GRANTED—
Jun 8, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 27, 2020DRRRDIVISIONAL REQUEST RECEIVED—
May 27, 2020EXT5SOU EXTENSION 5 FILED—
May 27, 2020ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 27, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 5, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 3, 2020EX4GSOU EXTENSION 4 GRANTED—
Feb 3, 2020EXT4SOU EXTENSION 4 FILED—
Feb 3, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 16, 2019EX3GSOU EXTENSION 3 GRANTED—
Jul 16, 2019EXT3SOU EXTENSION 3 FILED—
Jul 16, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 8, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 6, 2019EX2GSOU EXTENSION 2 GRANTED—
Feb 6, 2019EXT2SOU EXTENSION 2 FILED—
Feb 6, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 7, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2018EX1GSOU EXTENSION 1 GRANTED—
Aug 4, 2018EXT1SOU EXTENSION 1 FILED—
Aug 4, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 6, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 4, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 3, 2017ALIEASSIGNED TO LIE—
Oct 23, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 28, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 28, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 8, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 10, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 8, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 7, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 30, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 30, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 30, 2017DOCKASSIGNED TO EXAMINER—
Apr 17, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance